InvestorsHub Logo
Followers 14
Posts 698
Boards Moderated 0
Alias Born 04/06/2011

Re: A deleted message

Thursday, 05/14/2020 12:35:44 PM

Thursday, May 14, 2020 12:35:44 PM

Post# of 16703
Great points, 36% suffering these issues after current treatments!

Yes it sure seems like they have, just check out the Intro above or their web site.
NASH / Chronic Kidney Disease and IBD are targeted repurposed drug efforts. Maybe they have already thought of this when the recent PP cash raise was done. Some comments in recent news releases seem to imply other drug testing besides Ifenprodil...GLTA...